Cargando…
New oral anticoagulants – a practical guide
Oral direct inhibitors of thrombin and activated factor Xa are approved as new anticoagulant drugs. In contrast to vitamin K antagonists (VKA) and heparins, the new agents have single targets in the coagulation cascade and more predictable pharmacokinetics, but they lack validated and available anti...
Autores principales: | Ciurus, Tomasz, Sobczak, Sebastian, Cichocka-Radwan, Anna, Lelonek, Malgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550032/ https://www.ncbi.nlm.nih.gov/pubmed/26336492 http://dx.doi.org/10.5114/kitp.2015.52851 |
Ejemplares similares
-
Truly low and high thromboembolic risk – impact of risk scores in real life
por: Ciurus, Tomasz, et al.
Publicado: (2014) -
Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre
por: Ciurus, Tomasz, et al.
Publicado: (2015) -
The impact of chronic kidney disease on the annual prognosis in patients 80+ years old suffering from chronic heart failure
por: Cichocka-Radwan, Anna, et al.
Publicado: (2014) -
Operative survival in patients with acute aortic disease in the era of newer oral anticoagulants
por: Bjørnstad, Johannes Lagethon, et al.
Publicado: (2020) -
Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)